UniProt ID | PRS10_HUMAN | |
---|---|---|
UniProt AC | P62333 | |
Protein Name | 26S proteasome regulatory subunit 10B | |
Gene Name | PSMC6 | |
Organism | Homo sapiens (Human). | |
Sequence Length | 389 | |
Subcellular Localization | Cytoplasm. Nucleus. | |
Protein Description | Component of the 26S proteasome, a multiprotein complex involved in the ATP-dependent degradation of ubiquitinated proteins. This complex plays a key role in the maintenance of protein homeostasis by removing misfolded or damaged proteins, which could impair cellular functions, and by removing proteins whose functions are no longer required. Therefore, the proteasome participates in numerous cellular processes, including cell cycle progression, apoptosis, or DNA damage repair. PSMC6 belongs to the heterohexameric ring of AAA (ATPases associated with diverse cellular activities) proteins that unfolds ubiquitinated target proteins that are concurrently translocated into a proteolytic chamber and degraded into peptides.. | |
Protein Sequence | MADPRDKALQDYRKKLLEHKEIDGRLKELREQLKELTKQYEKSENDLKALQSVGQIVGEVLKQLTEEKFIVKATNGPRYVVGCRRQLDKSKLKPGTRVALDMTTLTIMRYLPREVDPLVYNMSHEDPGNVSYSEIGGLSEQIRELREVIELPLTNPELFQRVGIIPPKGCLLYGPPGTGKTLLARAVASQLDCNFLKVVSSSIVDKYIGESARLIREMFNYARDHQPCIIFMDEIDAIGGRRFSEGTSADREIQRTLMELLNQMDGFDTLHRVKMIMATNRPDTLDPALLRPGRLDRKIHIDLPNEQARLDILKIHAGPITKHGEIDYEAIVKLSDGFNGADLRNVCTEAGMFAIRADHDFVVQEDFMKAVRKVADSKKLESKLDYKPV | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
2 | Acetylation | ------MADPRDKAL ------CCCHHHHHH | 35.20 | - | |
7 | Ubiquitination | -MADPRDKALQDYRK -CCCHHHHHHHHHHH | 52.88 | 21906983 | |
7 | Acetylation | -MADPRDKALQDYRK -CCCHHHHHHHHHHH | 52.88 | 25953088 | |
15 | Acetylation | ALQDYRKKLLEHKEI HHHHHHHHHHHCHHH | 49.67 | 88589 | |
15 | Ubiquitination | ALQDYRKKLLEHKEI HHHHHHHHHHHCHHH | 49.67 | - | |
20 | Acetylation | RKKLLEHKEIDGRLK HHHHHHCHHHHHHHH | 47.17 | 19608861 | |
20 | Ubiquitination | RKKLLEHKEIDGRLK HHHHHHCHHHHHHHH | 47.17 | 21906983 | |
29 | Ubiquitination | IDGRLKELREQLKEL HHHHHHHHHHHHHHH | 7.54 | - | |
34 | Ubiquitination | KELREQLKELTKQYE HHHHHHHHHHHHHHH | 50.82 | 21906983 | |
34 | Acetylation | KELREQLKELTKQYE HHHHHHHHHHHHHHH | 50.82 | 19608861 | |
38 | Ubiquitination | EQLKELTKQYEKSEN HHHHHHHHHHHHCHH | 64.60 | - | |
41 | Ubiquitination | KELTKQYEKSENDLK HHHHHHHHHCHHHHH | 47.84 | - | |
42 | Ubiquitination | ELTKQYEKSENDLKA HHHHHHHHCHHHHHH | 59.12 | - | |
48 | Ubiquitination | EKSENDLKALQSVGQ HHCHHHHHHHHHHHH | 50.33 | 21906983 | |
52 | Ubiquitination | NDLKALQSVGQIVGE HHHHHHHHHHHHHHH | 29.12 | - | |
52 | Phosphorylation | NDLKALQSVGQIVGE HHHHHHHHHHHHHHH | 29.12 | 20068231 | |
62 | Ubiquitination | QIVGEVLKQLTEEKF HHHHHHHHHHCCCCE | 48.73 | - | |
66 | Phosphorylation | EVLKQLTEEKFIVKA HHHHHHCCCCEEEEC | 68.71 | 20068231 | |
68 | Acetylation | LKQLTEEKFIVKATN HHHHCCCCEEEECCC | 33.87 | 23236377 | |
72 | Ubiquitination | TEEKFIVKATNGPRY CCCCEEEECCCCCEE | 44.68 | - | |
72 | Malonylation | TEEKFIVKATNGPRY CCCCEEEECCCCCEE | 44.68 | 26320211 | |
72 | Acetylation | TEEKFIVKATNGPRY CCCCEEEECCCCCEE | 44.68 | 19608861 | |
76 | Ubiquitination | FIVKATNGPRYVVGC EEEECCCCCEEEEEE | 12.05 | - | |
82 | Ubiquitination | NGPRYVVGCRRQLDK CCCEEEEEECHHCCH | 6.81 | - | |
86 | Ubiquitination | YVVGCRRQLDKSKLK EEEEECHHCCHHHCC | 34.36 | 19608861 | |
86 | Acetylation | YVVGCRRQLDKSKLK EEEEECHHCCHHHCC | 34.36 | 19608861 | |
91 | Ubiquitination | RRQLDKSKLKPGTRV CHHCCHHHCCCCCEE | 67.29 | - | |
93 | Sumoylation | QLDKSKLKPGTRVAL HCCHHHCCCCCEEEE | 45.17 | - | |
96 | Phosphorylation | KSKLKPGTRVALDMT HHHCCCCCEEEEECC | 30.42 | 24043423 | |
102 | Sulfoxidation | GTRVALDMTTLTIMR CCEEEEECCHHHHHH | 2.99 | 21406390 | |
103 | Phosphorylation | TRVALDMTTLTIMRY CEEEEECCHHHHHHH | 20.51 | 20860994 | |
104 | Phosphorylation | RVALDMTTLTIMRYL EEEEECCHHHHHHHC | 18.44 | 20860994 | |
106 | Phosphorylation | ALDMTTLTIMRYLPR EEECCHHHHHHHCCC | 15.61 | 20860994 | |
117 | Phosphorylation | YLPREVDPLVYNMSH HCCCCCCCCEECCCC | 28.97 | - | |
118 | Phosphorylation | LPREVDPLVYNMSHE CCCCCCCCEECCCCC | 5.74 | - | |
120 | Phosphorylation | REVDPLVYNMSHEDP CCCCCCEECCCCCCC | 16.90 | 30624053 | |
122 | Sulfoxidation | VDPLVYNMSHEDPGN CCCCEECCCCCCCCC | 2.07 | 30846556 | |
123 | Phosphorylation | DPLVYNMSHEDPGNV CCCEECCCCCCCCCC | 21.78 | 30624053 | |
131 | Phosphorylation | HEDPGNVSYSEIGGL CCCCCCCCHHHCCCH | 27.26 | 30576142 | |
132 | Phosphorylation | EDPGNVSYSEIGGLS CCCCCCCHHHCCCHH | 13.16 | 30624053 | |
133 | Phosphorylation | DPGNVSYSEIGGLSE CCCCCCHHHCCCHHH | 18.41 | 30624053 | |
145 | Phosphorylation | LSEQIRELREVIELP HHHHHHHHHHHHCCC | 3.98 | - | |
168 | Ubiquitination | RVGIIPPKGCLLYGP HCCEECCCCEEEECC | 57.83 | 21906983 | |
173 | Phosphorylation | PPKGCLLYGPPGTGK CCCCEEEECCCCCCH | 18.03 | 20090780 | |
178 | Phosphorylation | LLYGPPGTGKTLLAR EEECCCCCCHHHHHH | 41.08 | 28152594 | |
180 | Ubiquitination | YGPPGTGKTLLARAV ECCCCCCHHHHHHHH | 35.52 | 21906983 | |
181 | Phosphorylation | GPPGTGKTLLARAVA CCCCCCHHHHHHHHH | 28.48 | - | |
182 | Ubiquitination | PPGTGKTLLARAVAS CCCCCHHHHHHHHHH | 3.92 | - | |
187 | Phosphorylation | KTLLARAVASQLDCN HHHHHHHHHHHCCCC | 4.37 | - | |
189 | Phosphorylation | LLARAVASQLDCNFL HHHHHHHHHCCCCHH | 25.36 | 30622161 | |
193 | S-nitrosylation | AVASQLDCNFLKVVS HHHHHCCCCHHHHHC | 5.43 | 19483679 | |
193 | Glutathionylation | AVASQLDCNFLKVVS HHHHHCCCCHHHHHC | 5.43 | 22555962 | |
193 | S-nitrosocysteine | AVASQLDCNFLKVVS HHHHHCCCCHHHHHC | 5.43 | - | |
194 | Ubiquitination | VASQLDCNFLKVVSS HHHHCCCCHHHHHCH | 44.97 | - | |
197 | Ubiquitination | QLDCNFLKVVSSSIV HCCCCHHHHHCHHHH | 36.13 | 21906983 | |
200 | Phosphorylation | CNFLKVVSSSIVDKY CCHHHHHCHHHHHHH | 22.73 | 26356563 | |
201 | Phosphorylation | NFLKVVSSSIVDKYI CHHHHHCHHHHHHHH | 16.69 | 28152594 | |
202 | Phosphorylation | FLKVVSSSIVDKYIG HHHHHCHHHHHHHHH | 21.08 | 28152594 | |
206 | Ubiquitination | VSSSIVDKYIGESAR HCHHHHHHHHHHHHH | 28.07 | 21890473 | |
206 | Acetylation | VSSSIVDKYIGESAR HCHHHHHHHHHHHHH | 28.07 | 19608861 | |
206 | Malonylation | VSSSIVDKYIGESAR HCHHHHHHHHHHHHH | 28.07 | 26320211 | |
207 | Phosphorylation | SSSIVDKYIGESARL CHHHHHHHHHHHHHH | 15.08 | 27273156 | |
211 | Phosphorylation | VDKYIGESARLIREM HHHHHHHHHHHHHHH | 17.30 | 28152594 | |
211 | Ubiquitination | VDKYIGESARLIREM HHHHHHHHHHHHHHH | 17.30 | - | |
218 | Sulfoxidation | SARLIREMFNYARDH HHHHHHHHHHHHHCC | 1.57 | 30846556 | |
220 | Ubiquitination | RLIREMFNYARDHQP HHHHHHHHHHHCCCC | 28.39 | 19608861 | |
220 | Acetylation | RLIREMFNYARDHQP HHHHHHHHHHHCCCC | 28.39 | 19608861 | |
221 | Phosphorylation | LIREMFNYARDHQPC HHHHHHHHHHCCCCE | 7.55 | 18083107 | |
228 | Glutathionylation | YARDHQPCIIFMDEI HHHCCCCEEEEECCC | 2.76 | 22555962 | |
232 | Sulfoxidation | HQPCIIFMDEIDAIG CCCEEEEECCCCCCC | 2.96 | 30846556 | |
244 | Phosphorylation | AIGGRRFSEGTSADR CCCCCCCCCCCCHHH | 33.05 | 29255136 | |
247 | Phosphorylation | GRRFSEGTSADREIQ CCCCCCCCCHHHHHH | 19.38 | 23403867 | |
248 | Phosphorylation | RRFSEGTSADREIQR CCCCCCCCHHHHHHH | 38.74 | 23403867 | |
258 | Phosphorylation | REIQRTLMELLNQMD HHHHHHHHHHHHHCC | 3.18 | 27251275 | |
274 | Ubiquitination | FDTLHRVKMIMATNR CCHHHHHHHHHHCCC | 23.75 | 21906983 | |
288 | Ubiquitination | RPDTLDPALLRPGRL CCCCCCHHHCCCCCC | 20.92 | - | |
298 | Ubiquitination | RPGRLDRKIHIDLPN CCCCCCCEEECCCCC | 38.00 | 21906983 | |
298 | Sumoylation | RPGRLDRKIHIDLPN CCCCCCCEEECCCCC | 38.00 | - | |
312 | Ubiquitination | NEQARLDILKIHAGP CHHHHCCEEEECCCC | 5.10 | - | |
314 | Acetylation | QARLDILKIHAGPIT HHHCCEEEECCCCCC | 32.55 | 25953088 | |
314 | Ubiquitination | QARLDILKIHAGPIT HHHCCEEEECCCCCC | 32.55 | - | |
322 | Ubiquitination | IHAGPITKHGEIDYE ECCCCCCCCCCCCHH | 50.78 | 21906983 | |
328 | Ubiquitination | TKHGEIDYEAIVKLS CCCCCCCHHHEEECC | 16.96 | - | |
328 | Phosphorylation | TKHGEIDYEAIVKLS CCCCCCCHHHEEECC | 16.96 | 28152594 | |
333 | Ubiquitination | IDYEAIVKLSDGFNG CCHHHEEECCCCCCH | 35.84 | - | |
336 | Ubiquitination | EAIVKLSDGFNGADL HHEEECCCCCCHHHH | 75.93 | - | |
342 | Phosphorylation | SDGFNGADLRNVCTE CCCCCHHHHHHHHHH | 47.78 | - | |
347 | Ubiquitination | GADLRNVCTEAGMFA HHHHHHHHHHHHCEE | 3.04 | - | |
347 | Glutathionylation | GADLRNVCTEAGMFA HHHHHHHHHHHHCEE | 3.04 | 22555962 | |
352 | Sulfoxidation | NVCTEAGMFAIRADH HHHHHHHCEEEECCC | 2.36 | 21406390 | |
368 | Sulfoxidation | FVVQEDFMKAVRKVA EECCHHHHHHHHHHH | 4.16 | 21406390 | |
369 | Ubiquitination | VVQEDFMKAVRKVAD ECCHHHHHHHHHHHC | 43.66 | - | |
383 | Ubiquitination | DSKKLESKLDYKPV- CHHHHHHHCCCCCC- | 35.68 | 21906983 | |
386 | Phosphorylation | KLESKLDYKPV---- HHHHHCCCCCC---- | 27.85 | - | |
397 | Ubiquitination | --------------- --------------- | - |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of PRS10_HUMAN !! |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of PRS10_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of PRS10_HUMAN !! |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Acetylation | |
Reference | PubMed |
"Mass spectrometric characterization of the affinity-purified human26S proteasome complex."; Wang X., Chen C.-F., Baker P.R., Chen P.-L., Kaiser P., Huang L.; Biochemistry 46:3553-3565(2007). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, AND MASS SPECTROMETRY. | |
"Lysine acetylation targets protein complexes and co-regulates majorcellular functions."; Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.,Olsen J.V., Mann M.; Science 325:834-840(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-20; LYS-72 AND LYS-206, ANDMASS SPECTROMETRY. | |
Phosphorylation | |
Reference | PubMed |
"Global survey of phosphotyrosine signaling identifies oncogenickinases in lung cancer."; Rikova K., Guo A., Zeng Q., Possemato A., Yu J., Haack H., Nardone J.,Lee K., Reeves C., Li Y., Hu Y., Tan Z., Stokes M., Sullivan L.,Mitchell J., Wetzel R., Macneill J., Ren J.M., Yuan J.,Bakalarski C.E., Villen J., Kornhauser J.M., Smith B., Li D., Zhou X.,Gygi S.P., Gu T.-L., Polakiewicz R.D., Rush J., Comb M.J.; Cell 131:1190-1203(2007). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-207, AND MASSSPECTROMETRY. |